26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

paroxysmal cold hemoglobinuria (PCH) 556 passive agglutination<br />

atrophy of the fundal mucosa, achlororhydria, tendency to<br />

evolve into pernicious anemia, and association with autoimmune<br />

endocrine disease are characteristic. PCAs can be<br />

detected by incomplete Freund’s adjuvant (IFA) as reticular<br />

cytoplasmic staining using mouse stomach frozen sections.<br />

PCAs have been found in 100% of patients with primary<br />

biliary cirrhosis, in three fourths of cases of autoimmune<br />

hepatitis, and in 29% of patients with chronic liver disease.<br />

paroxysmal cold hemoglobinuria (PCH)<br />

A rare type of disease that accounts for 10% of cold autoimmune<br />

hemolytic anemias. It may be a primary idiopathic<br />

disease or secondary to syphilis or viral infection and is<br />

characterized by the passage of hemoglobin in the urine after<br />

exposure to cold. In addition to passing dark brown urine,<br />

a patient may experience chills, fever, and pain in the back,<br />

legs, or abdomen. The disease is associated with a hemolysin<br />

termed the Donath–Landsteiner antibody, a polyclonal immunoglobulin<br />

G (IgG) antibody. It sensitizes red blood cells in<br />

the cold, complement attaches to the erythrocyte surface, and<br />

hemolysis occurs on warming to 37°C. The specificity of the<br />

antibody is for the P antigen of red blood cells.<br />

paroxysmal nocturnal hemoglobinuria (PNH)<br />

A rare form of hemolytic anemia in which the red blood<br />

cells, neutrophils, and platelets manifest strikingly increased<br />

sensitivity to complement lysis. An acquired membrane defect<br />

secondary to a mutation that affects myeloid stem cells. The<br />

mutant PIGA gene is requisite for the synthesis of a precise<br />

intramembranous glycolipid anchor called phosphatidyl inositol<br />

glycan (PIG), a component of diverse membrane-associated<br />

proteins. This membrane anchor is necessary for the expression<br />

of PIG-tailed proteins on cell surfaces. The affected proteins<br />

include some that limit the spontaneous activation of complement<br />

at the cell surface. Thus, PIG-deficient precursors give<br />

rise to red cells that are especially sensitive to the lytic action of<br />

complement. The hemolysis is nocturnal as the blood becomes<br />

acidic during sleep because of CO 2 retention and an acid pH<br />

may facilitate hemolysis. PNH red blood cell membranes are<br />

deficient in decay-accelerating factor (DAF), leukocyte-function-associated<br />

antigen 3 (LFA-3), and FcRIII. Without DAF,<br />

which protects the cell membranes from complement lysis<br />

by classic pathway C5 convertase and decreases membrane<br />

attack complex formation, the erythrocytes and lymphocytes<br />

are highly susceptible to lysis by complement. Interaction of<br />

these PNH erythrocytes with activated complement results in<br />

excessive C3b binding, which leads to the formation of more<br />

C3b through the alternate complement pathway by way of<br />

factors B and D. Intravascular hemolysis follows activation<br />

of C5 convertase in the C5–C9 membrane attack complex<br />

(MAC). The blood platelets and myelocytes in affected subjects<br />

are also DAF-deficient and are readily lysed by complement.<br />

Leukopenia, thrombocytopenia, iron deficiency, and<br />

diminished leukocyte alkaline phosphatase are observed. The<br />

Coombs’ test is negative, and acetylcholine esterase activity in<br />

the red cell membrane is very low. No antibody participating in<br />

this process has been found in either the serum or on the erythrocytes.<br />

The disease is suggested by episodes of intravascular<br />

hemolysis, iron deficiency, and hemosiderin in the urine. It is<br />

confirmed by hemolysis in acid medium, termed the HAM test.<br />

partial agonist<br />

Refer to altered peptide ligands.<br />

partial identity<br />

Refer to reaction of partial identity.<br />

parvovirus<br />

A minute icosahedral virus composed of single-stranded<br />

DNA that may replicate in previously uninfected host cells<br />

or in those already infected with adenovirus.<br />

parvovirus immunity<br />

Specific immunoglobulin M (IgM) followed by IgG antibodies<br />

that occur in the second week of exposure can effectively<br />

clear parvovirus infection. Parvovirus B19 targets<br />

the erythroid bone marrow cells. Antibodies that develop<br />

following first exposure to the virus are specific mainly for<br />

VP2 epitopes. This is followed by antibodies that are specific<br />

for VP1 epitopes. VP1-unique region linear epitopes<br />

are critical to induce effective neutralizing antibodies. IgG<br />

antibodies persist for life. Immunodeficient individuals who<br />

cannot develop adequate antibody responses may develop<br />

persistent parvovirus infection. VP1-specific antibodies<br />

are crucial for the control of parvovirus B19 infection.<br />

Commercial immunoglobulin preparations contain<br />

parvovirus B19 neutralizing antibody and are useful for<br />

the treatment of persistent parvovirus infection. Antibody<br />

synthesis in immunocompetent subjects prevents clinical<br />

manifestations as a consequence of direct viral cytotoxicity.<br />

Immunodeficient patients who have impaired capacity to<br />

synthesize neutralizing antibodies develop severe anemia<br />

as a result of suppressed erythropoiesis by the virus. Empty<br />

parvovirus capsids enriched for VP1 epitopes induce protective<br />

antibody responses. A recombinant form has shown<br />

promise in clinical trials.<br />

PAS<br />

(1) Abbreviation for periodic acid Schiff stain for polysaccharides.<br />

This technique identifies mucopolysaccharide,<br />

glycogen, and sialic acid among other chemicals containing<br />

1,2-diol groups. (2) Abbreviation for para-aminosalicylic<br />

acid, used in the treatment of tuberculosis.<br />

passive agglutination<br />

The aggregation of particles with soluble antigens adsorbed<br />

to their surfaces by a homologous antibody. The soluble antigen<br />

may be linked to the particle surface through covalent<br />

bonds rather than by mere adsorption. Red blood cells, latex,<br />

bentonite, or collodion particles may be used as carriers for<br />

antigen molecules adsorbed to their surfaces. When a red<br />

blood cell is used as a carrier particle, its surface has to be<br />

altered to facilitate maximal adsorption of the antigen to its<br />

surface. Several techniques are employed to accomplish this.<br />

One is the tanned red blood cell technique, which involves<br />

treating the cells with a tannic acid solution that alters<br />

their surfaces in a manner favoring the adsorption of added<br />

soluble antigen. A second method is the treatment of red cell<br />

preparations with other chemicals such as bis-diazotized<br />

benzidine. With this passive agglutination technique, even<br />

relatively minute quantities of soluble antigens may be<br />

detected by the homologous antibody-agglutinating carrier<br />

cells on which they are adsorbed. Because red blood cells<br />

are the most commonly employed particles, the technique is<br />

referred to as passive hemagglutination. Latex particles are<br />

used in the rheumatoid arthritis (RA) test, in which pooled<br />

immunoglobulin G (IgG) molecules are adsorbed to latex<br />

particles and reacted with the sera of patients with rheumatoid<br />

arthritis that contain rheumatoid factor (IgM anti-IgG<br />

antibody) to produce agglutination. Polysaccharide antigens<br />

will stick to red blood cells without treatment. When proteins<br />

are used, however, covalent linkages are required.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!